How has Aurinia Pharmaceuticals's other accrued liabilities changed year-over-year?

Aurinia Pharmaceuticals's other accrued liabilities increased by 0.1% year-over-year, from $7.99M to $8M.

What is the long-term trend for Aurinia Pharmaceuticals's other accrued liabilities?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's other accrued liabilities has grown at a 1.5% compound annual growth rate (CAGR), from $6.62M to $7.14M.

Aurinia Pharmaceuticals AUPH Other accrued liabilities

Other accrued liabilities at other companies

Agios PharmaceuticalsAGIO

——

Ligand PharmaceuticalsLGND

——

BridgeBio PharmaBBIO

——

Ionis PharmaceuticalsIONS

——

AbbottABT

——

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.39B+78.5%

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's other accrued liabilities?: Aurinia Pharmaceuticals (AUPH) reported other accrued liabilities of $8M in Q1 2026.
How has Aurinia Pharmaceuticals's other accrued liabilities changed year-over-year?: Aurinia Pharmaceuticals's other accrued liabilities increased by 0.1% year-over-year, from $7.99M to $8M.
What is the long-term trend for Aurinia Pharmaceuticals's other accrued liabilities?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's other accrued liabilities has grown at a 1.5% compound annual growth rate (CAGR), from $6.62M to $7.14M.